October 3, 2025

What's new about cutaneous T-cell lymphoma?

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis reveals improved treatment options for cutaneous T-cell lymphoma, suggesting new hope for patients.

CTCL diagnosis relies on clinical examination, skin biopsy, and blood tests to assess systemic involvement.
Novel targeted therapies like brentuximab vedotin and mogamulizumab offer more effective treatment options for CTCL.
Quality of life in CTCL patients is often compromised due to symptoms such as chronic itching and stigmatizing skin lesions.
Allogeneic stem cell transplantation is currently regarded as the only curative approach for CTCL patients.

A Roggo (2025) studied this question.

View Full Paper

Ask AI

Bookmark